IAXO-102

N/A

Report date: 2025/01/26 16:59:41
NME

Base Information

Drug NameIAXO-102
Drug Alias NameIAXO-102
ClassificationSmall molecules > Lipid
Mechanisms of ActionMonocyte differentiation antigen CD14 inhibitorsToll like receptor 4 inhibitors
TargetsMonocyte differentiation antigen CD14Toll like receptor 4
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesInnaxon
China Registration ClassN/A

Develop Information

Active CompaniesInnaxon
Inactive CompaniesN/A
Active IndicationsInflammation
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A